Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
2003 1
2006 1
2007 1
2008 2
2009 1
2011 1
2012 1
2013 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies.
Presutti DG, D'Ascenzo F, Omedè P, Biondi-Zoccai G, Moretti C, Bollati M, Sciuto F, Lee MS, Moreno R, Bikkina M, Di Cuia M, Resmini C, Gaita F, Sheiban I. Presutti DG, et al. Among authors: resmini c. J Cardiovasc Med (Hagerstown). 2013 Nov;14(11):773-9. doi: 10.2459/JCM.0b013e3283619410. J Cardiovasc Med (Hagerstown). 2013. PMID: 23756410 Review.
Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.
Hu B, Collini M, Unwalla R, Miller C, Singhaus R, Quinet E, Savio D, Halpern A, Basso M, Keith J, Clerin V, Chen L, Resmini C, Liu QY, Feingold I, Huselton C, Azam F, Farnegardh M, Enroth C, Bonn T, Goos-Nilsson A, Wilhelmsson A, Nambi P, Wrobel J. Hu B, et al. Among authors: resmini c. J Med Chem. 2006 Oct 19;49(21):6151-4. doi: 10.1021/jm0609566. J Med Chem. 2006. PMID: 17034119
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis.
Bedard PW, Clerin V, Sushkova N, Tchernychev B, Antrilli T, Resmini C, Keith JC Jr, Hennan JK, Kaila N, Debernardo S, Janz K, Wang Q, Crandall DL, Schaub RG, Shaw GD, Carter LL. Bedard PW, et al. Among authors: resmini c. J Pharmacol Exp Ther. 2008 Feb;324(2):497-506. doi: 10.1124/jpet.107.128124. Epub 2007 Nov 16. J Pharmacol Exp Ther. 2008. PMID: 18024786
Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease.
Meliga E, Fiorina C, Valgimigli M, Belli R, Gagnor A, Sheiban I, Resmini C, Tizzani E, Aranzulla T, Scrocca I, DE Benedictis M, Conte MR. Meliga E, et al. Among authors: resmini c. J Interv Cardiol. 2011 Dec;24(6):535-41. doi: 10.1111/j.1540-8183.2011.00666.x. Epub 2011 Oct 20. J Interv Cardiol. 2011. PMID: 22010970 Free article.
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
Quinet EM, Basso MD, Halpern AR, Yates DW, Steffan RJ, Clerin V, Resmini C, Keith JC, Berrodin TJ, Feingold I, Zhong W, Hartman HB, Evans MJ, Gardell SJ, DiBlasio-Smith E, Mounts WM, LaVallie ER, Wrobel J, Nambi P, Vlasuk GP. Quinet EM, et al. Among authors: resmini c. J Lipid Res. 2009 Dec;50(12):2358-70. doi: 10.1194/jlr.M900037-JLR200. Epub 2009 Mar 24. J Lipid Res. 2009. PMID: 19318684 Free PMC article.
Immunoglobulin isotype modulation after administration of IL-12.
Van Cleave V, Wolf S, Murray K, Wiencis A, Ketchum M, Bliss J, Haire T, Resmini C, Maylor R, Alderman E. Van Cleave V, et al. Among authors: resmini c. Adv Exp Med Biol. 1995;383:43-52. doi: 10.1007/978-1-4615-1891-4_6. Adv Exp Med Biol. 1995. PMID: 8644512
12 results